OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genetic and epigenetic drivers of neuroendocrine tumours (NET)
Annunziata Di Domenico, Tabea Wiedmer, Ilaria Marinoni, et al.
Endocrine Related Cancer (2017) Vol. 24, Iss. 9, pp. R315-R334
Open Access | Times Cited: 124
Annunziata Di Domenico, Tabea Wiedmer, Ilaria Marinoni, et al.
Endocrine Related Cancer (2017) Vol. 24, Iss. 9, pp. R315-R334
Open Access | Times Cited: 124
Showing 1-25 of 124 citing articles:
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
Bryan Oronsky, C. Patrick, Daniel Morgensztern, et al.
Neoplasia (2017) Vol. 19, Iss. 12, pp. 991-1002
Open Access | Times Cited: 620
Bryan Oronsky, C. Patrick, Daniel Morgensztern, et al.
Neoplasia (2017) Vol. 19, Iss. 12, pp. 991-1002
Open Access | Times Cited: 620
Gastroenteropancreatic Neuroendocrine Tumors
Mauro Cives, Jonathan Strosberg
CA A Cancer Journal for Clinicians (2018) Vol. 68, Iss. 6, pp. 471-487
Open Access | Times Cited: 494
Mauro Cives, Jonathan Strosberg
CA A Cancer Journal for Clinicians (2018) Vol. 68, Iss. 6, pp. 471-487
Open Access | Times Cited: 494
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study
Jianming Xu, Lin Shen, Zhiwei Zhou, et al.
The Lancet Oncology (2020) Vol. 21, Iss. 11, pp. 1500-1512
Closed Access | Times Cited: 149
Jianming Xu, Lin Shen, Zhiwei Zhou, et al.
The Lancet Oncology (2020) Vol. 21, Iss. 11, pp. 1500-1512
Closed Access | Times Cited: 149
DAXX in cancer: phenomena, processes, mechanisms and regulation
Iqbal Mahmud, Daiqing Liao
Nucleic Acids Research (2019) Vol. 47, Iss. 15, pp. 7734-7752
Open Access | Times Cited: 103
Iqbal Mahmud, Daiqing Liao
Nucleic Acids Research (2019) Vol. 47, Iss. 15, pp. 7734-7752
Open Access | Times Cited: 103
Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium
Andrea Mafficini, Aldo Scarpa
Journal of Endocrinology (2018) Vol. 236, Iss. 3, pp. R161-R167
Open Access | Times Cited: 85
Andrea Mafficini, Aldo Scarpa
Journal of Endocrinology (2018) Vol. 236, Iss. 3, pp. R161-R167
Open Access | Times Cited: 85
The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours
Aldo Scarpa
Annales d Endocrinologie (2019) Vol. 80, Iss. 3, pp. 153-158
Open Access | Times Cited: 77
Aldo Scarpa
Annales d Endocrinologie (2019) Vol. 80, Iss. 3, pp. 153-158
Open Access | Times Cited: 77
Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression
Annunziata Di Domenico, Christodoulos P. Pipinikas, Renaud Maire, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 77
Annunziata Di Domenico, Christodoulos P. Pipinikas, Renaud Maire, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 77
Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies
Christoph J. Auernhammer, Christine Spitzweg, Martin K. Angele, et al.
The Lancet Diabetes & Endocrinology (2017) Vol. 6, Iss. 5, pp. 404-415
Closed Access | Times Cited: 66
Christoph J. Auernhammer, Christine Spitzweg, Martin K. Angele, et al.
The Lancet Diabetes & Endocrinology (2017) Vol. 6, Iss. 5, pp. 404-415
Closed Access | Times Cited: 66
Prognostic and predictive factors on overall survival and surgical outcomes in pancreatic neuroendocrine tumors: recent advances and controversies
Lingaku Lee, Tetsuhide Ito, Robert T. Jensen
Expert Review of Anticancer Therapy (2019) Vol. 19, Iss. 12, pp. 1029-1050
Open Access | Times Cited: 66
Lingaku Lee, Tetsuhide Ito, Robert T. Jensen
Expert Review of Anticancer Therapy (2019) Vol. 19, Iss. 12, pp. 1029-1050
Open Access | Times Cited: 66
Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer
Maria J. Klomp, Simone U. Dalm, Marion de Jong, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 22, Iss. 3, pp. 495-510
Open Access | Times Cited: 53
Maria J. Klomp, Simone U. Dalm, Marion de Jong, et al.
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 22, Iss. 3, pp. 495-510
Open Access | Times Cited: 53
Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls
Björn Konukiewitz, Moritz Jesinghaus, Atsuko Kasajima, et al.
Virchows Archiv (2021) Vol. 480, Iss. 2, pp. 247-257
Open Access | Times Cited: 41
Björn Konukiewitz, Moritz Jesinghaus, Atsuko Kasajima, et al.
Virchows Archiv (2021) Vol. 480, Iss. 2, pp. 247-257
Open Access | Times Cited: 41
An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms
Jiayun M. Fang, Jay Li, Jiaqi Shi
World Journal of Gastroenterology (2022) Vol. 28, Iss. 10, pp. 1009-1023
Open Access | Times Cited: 31
Jiayun M. Fang, Jay Li, Jiaqi Shi
World Journal of Gastroenterology (2022) Vol. 28, Iss. 10, pp. 1009-1023
Open Access | Times Cited: 31
Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors
Simon April-Monn, Tabea Wiedmer, Magdalena Skowronska, et al.
Neuroendocrinology (2020) Vol. 111, Iss. 3, pp. 273-287
Open Access | Times Cited: 49
Simon April-Monn, Tabea Wiedmer, Magdalena Skowronska, et al.
Neuroendocrinology (2020) Vol. 111, Iss. 3, pp. 273-287
Open Access | Times Cited: 49
A rare rarity: Neuroendocrine tumor of the esophagus
Elisa Giannetta, Valentina Guarnotta, Francesca Silvia Rota, et al.
Critical Reviews in Oncology/Hematology (2019) Vol. 137, pp. 92-107
Closed Access | Times Cited: 46
Elisa Giannetta, Valentina Guarnotta, Francesca Silvia Rota, et al.
Critical Reviews in Oncology/Hematology (2019) Vol. 137, pp. 92-107
Closed Access | Times Cited: 46
Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms
Raul S. González
Surgical pathology clinics (2020) Vol. 13, Iss. 3, pp. 377-397
Closed Access | Times Cited: 43
Raul S. González
Surgical pathology clinics (2020) Vol. 13, Iss. 3, pp. 377-397
Closed Access | Times Cited: 43
Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
Martine Bocchini, Fabio Nicolini, Stefano Severi, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 39
Martine Bocchini, Fabio Nicolini, Stefano Severi, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 39
Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor
Yu Zhou, Si‐Yang Maggie Liu, Chao Liu, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 14, pp. 3760-3775
Open Access | Times Cited: 34
Yu Zhou, Si‐Yang Maggie Liu, Chao Liu, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 14, pp. 3760-3775
Open Access | Times Cited: 34
Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma Primary Cultures
Katharina Wang, Laura Schober, Alessa Fischer, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 5
Katharina Wang, Laura Schober, Alessa Fischer, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 5
Imaging update of pancreatic neuroendocrine neoplasms
Eric Rupe, Mahmoud Diab, LeeAnn Xoubi, et al.
Seminars in Roentgenology (2025) Vol. 60, Iss. 1, pp. 31-43
Closed Access
Eric Rupe, Mahmoud Diab, LeeAnn Xoubi, et al.
Seminars in Roentgenology (2025) Vol. 60, Iss. 1, pp. 31-43
Closed Access
Prognosis of small pancreatic neuroendocrine neoplasms: functionality matters
Qingquan Tan, Li Liu, Xubao Liu, et al.
The American Journal of Surgery (2025), pp. 116302-116302
Closed Access
Qingquan Tan, Li Liu, Xubao Liu, et al.
The American Journal of Surgery (2025), pp. 116302-116302
Closed Access
Enhancer of zeste homolog 2 (EZH2) in endocrine tumors: current knowledge and future directions
Poonam Kumari, Sheenam Garg, Ashutosh Kumar Arya, et al.
Expert Opinion on Therapeutic Targets (2025)
Closed Access
Poonam Kumari, Sheenam Garg, Ashutosh Kumar Arya, et al.
Expert Opinion on Therapeutic Targets (2025)
Closed Access
PANCREATIC NEUROENDOCRINE NEOPLASMS (pNENs): GENETIC AND ENVIRONMENTAL BIOMARKERS FOR RISK OF OCCURRENCE AND PROGNOSIS
Matteo Tacelli, Manuel Gentiluomo, Paolo Biamonte, et al.
Seminars in Cancer Biology (2025)
Closed Access
Matteo Tacelli, Manuel Gentiluomo, Paolo Biamonte, et al.
Seminars in Cancer Biology (2025)
Closed Access
Combination of 5-Fluorouracil with Epigenetic Modifiers Induces Radiosensitization, Somatostatin Receptor 2 Expression, and Radioligand Binding in Neuroendocrine Tumor Cells In Vitro
Xi‐Feng Jin, Christoph J. Auernhammer, Harun Ilhan, et al.
Journal of Nuclear Medicine (2019) Vol. 60, Iss. 9, pp. 1240-1246
Open Access | Times Cited: 40
Xi‐Feng Jin, Christoph J. Auernhammer, Harun Ilhan, et al.
Journal of Nuclear Medicine (2019) Vol. 60, Iss. 9, pp. 1240-1246
Open Access | Times Cited: 40
Blood-based next-generation sequencing analysis of neuroendocrine neoplasms
Katerina Zakka, Rebecca J. Nagy, Leylah Drusbosky, et al.
Oncotarget (2020) Vol. 11, Iss. 19, pp. 1749-1757
Open Access | Times Cited: 37
Katerina Zakka, Rebecca J. Nagy, Leylah Drusbosky, et al.
Oncotarget (2020) Vol. 11, Iss. 19, pp. 1749-1757
Open Access | Times Cited: 37
Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead
Annamaria Colao, Filomena de Nigris, Roberta Modica, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 36
Annamaria Colao, Filomena de Nigris, Roberta Modica, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 36
